Valitor
Berkeley
About Valitor
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $39.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2022)
- Website: valitorbio.com
- Phone: (510) 969-9246
Industries & Categories
Biotechnology, Developer Tools, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/valitor-17343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.